65 I B, drugs, pharmaceuticals,&hematology related products, FSS contract award
Ended Awarded Last action
- Contract number
- 36F79719D0224
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 81
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $25,861,477.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
Horizon Therapeutics USA Inc. holds a Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) awarded by the Department of Veterans Affairs on August 15, 2019, with a ceiling value of $25.86 million and an ultimate completion date of September 30, 2025. This multiple-award contract vehicle enables the Veterans Health Administration (VHA) and its subordinate Veterans Integrated Service Networks (VISNs) to issue firm fixed-price delivery orders for specialty pharmaceutical products without conducting separate competitive procurements for each purchase. The primary product delivered under this contract is KRYSTEXXA (pegloticase) 8 milligram formulations, used to treat chronic gout in veteran populations, with manufacturing and distribution occurring from Horizon's facilities in La Vergne, Tennessee, and supplementary locations in Riverwoods and Lake Forest, Illinois. No set-aside designations were used for this award, and delivery orders have been consistently placed by VISN 5, VISN 19, VISN 20, and VISN 22 across the national VA healthcare system. Horizon Therapeutics has supplemented this base FSS contract with two Blanket Purchase Agreements (BPAs)—one valued at $18.045 million (awarded September 20, 2019, expiring September 19, 2024) and a successor BPA valued at $31.375 million (awarded September 20, 2024, expiring October 29, 2025)—which expand the product portfolio to include Ravicti, Buphenyl, Procysbi, Actimmune, and Uplizna, broadening access to Horizon's specialty medications for rare, autoimmune, and severe inflammatory diseases across the VA network.
The delivery orders issued under this contract vehicle demonstrate sustained demand from the VA healthcare system, with individual task orders ranging from approximately $16,600 to $591,250 in value and completion dates spanning from early 2022 through early 2025. These orders facilitate the procurement of critical orphan drugs and specialty pharmaceuticals required to support the VHA's mission of providing comprehensive healthcare services to the veteran population. Horizon Therapeutics operates as the sole prime contractor under these vehicles, with no identified subcontractors, ensuring direct control over product quality and delivery timelines. The firm fixed-price structure of all delivery orders provides budgetary predictability for the VA while enabling rapid procurement of medically necessary specialty pharmaceuticals to support various VA medical centers and regional networks nationwide. This contracting approach reflects the federal government's strategy of utilizing pre-competed GSA Schedule vehicles to streamline the acquisition of specialty drugs for which limited alternative suppliers exist, thereby reducing procurement cycle times while maintaining competitive pricing through the underlying Schedule negotiation process.
Task orders
Show 40 more
Latest 50 of 81 listed here. See the rest on GovTribe.
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79724A0031 | National Acquisition Center (VA) | $31,375,000 | |
| 36E79719A0032 | National Acquisition Center (VA) | $18,045,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 32
Quick answers
Who was awarded contract 36F79719D0224?
36F79719D0224 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 15, 2019.
How much is contract 36F79719D0224 worth?
36F79719D0224's own ceiling is $25,861,477.
How many orders have been placed under contract 36F79719D0224?
81 orders have been placed under 36F79719D0224, the latest on February 28, 2025.
Who can order from contract 36F79719D0224?
36F79719D0224 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79719D0224 part of a contract vehicle?
Yes. 36F79719D0224 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79719D0224 competed?
The extent of competition for 36F79719D0224 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV